Cabaletta Bio, Inc.
CABA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $112 | $929 | $271 | $98 |
| - Cash | $164 | $193 | $82 | $122 |
| + Debt | $16 | $5 | $5 | $0 |
| Enterprise Value | -$36 | $741 | $195 | -$25 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$5 | -$1 | -$4 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$110 | -$66 | -$49 | -$46 |
| % Margin | – | – | – | – |
| Net Income | -$116 | -$68 | -$53 | -$46 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.34 | -1.65 | -1.81 | -1.8 |
| % Growth | -41.8% | 8.8% | -0.6% | – |
| Operating Cash Flow | -$88 | -$54 | -$46 | -$34 |
| Capital Expenditures | -$2 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$90 | -$54 | -$49 | -$35 |